According to a market report by Lucintel, the future of the global dialysate calibrator market looks promising with opportunities in the hospital & dialysis center, dialysis fluid manufacturer, and medical device testing institution markets. The global dialysate calibrator market is expected to grow with a CAGR of 6.8% from 2025 to 2031. The major drivers for this market are the increasing prevalence of kidney diseases, the rising demand for dialysis treatments, and the growing adoption of advanced diagnostics.
A more
than 150-page report to understand trends, opportunity and forecast in global dialysate
calibrator market to 2031 by type (electrolyte calibrators, pH calibrators,
osmolality calibrators, and comprehensive calibrators), application (hospitals
& dialysis centers, dialysis fluid manufacturers, medical device testing
institutions, and others), and region (North America, Europe, Asia Pacific, and
the Rest of the World).
Lucintel
forecasts that, within the type category, comprehensive calibrator is expected
to witness the highest growth over the forecast period.
Within the
application category, hospital & dialysis center is expected to witness the
highest growth.
Download
sample by clicking on dialysate
calibrator market.
In terms
of region, APAC is expected to witness the highest growth over the forecast
period.
Merck,
Baxter International, Fresenius Medical Care, Nipro Corporation, MesaLabs,
RANDOX Laboratories, Roche Diagnostics, Abbott Laboratories, Hunan Toujing Life
Science, Beijing Putian Tongchuang Biotechnology are the major suppliers in the
dialysate calibrator market.
This unique research
report will enable you to make confident business decisions in this globally
competitive marketplace. For a detailed table of contents, contact Lucintel at
+1-972-636-5056 or write us at helpdesk@lucintel.com to get
access of more than 1000 reports at fraction of cost visit Lucintel's Analytics
Dashboard.
About Lucintel
At Lucintel, we offer solutions for
you growth through game changer ideas and robust market &
unmet needs analysis. We are based in
Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20
years. We are quoted in several publications like the Wall Street Journal,
ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1-972-636-5056
Explore Our Latest Publications
Animal Origin Free Recombinant Trypsin Market
Automatic Erythrocyte Sedimentation Rate Analyzer Market
Biomedical Monodisperse Microsphere Market
No comments:
Post a Comment